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Summary: We describe a systematic examination of oraithine decarboxylase activity in 120 colonic mucosal
samples which were obtained from 20 subjects without colonic disease to establish the normal mean and standard
deviation from proximal to distal colon. Ornithine decarboxylase activity was determined by releasing CO2 from
Z)L-[l-14C]omithine. The mean ornithine decarboxylase levels (CO2 liberated) ranged from 0.26 ± 0.08 nmol/h-mg
protein in the caecum to 0.44 ±0.16 nmol/h · mg protein in the rectum. There was no difference between sex and
age. Ornithine decarboxylase was not stimulated by guanosine 5'-triphosphate. -Difluoromethylornithine showed
an ornithine decarboxylase inhibition of 97.1%. Ornithine decarboxylase activity can be measured with reliable
precision and reproducibility. The knowledge of the normal range of ornithine decarboxylase activity in normal
human colonic mucosa is necessary for the determination of ornithine decarboxylase activity in pathological find-
ings, especially in malignant transformation.
Introduction
Ornithine decarboxylase2) catalyzes the first step in the
biosynthesis of polyamines with the formation of putres-
cine and CO2 from L-ornithine utilizing pyridoxal-5-
phosphate as a cofactor (1—3). Ornithine decarboxylase
is a highly regulated enzyme with a very short in vivo
half-life of 10—20 minutes (4). It is a key enzyme in the
regulation of growth processes and cell proliferation (5).
Ornithine decarboxylase is a very minor component of
the total soluble protein in most cells and can be induced
by a large variety of growth-promoting stimuli such as
hormones, growth factors, tissue regeneration activities,
drugs and bile acids (6—10). There are existing multiple
isoforms of ornithine decarboxylase in mammalian cells
(11), of which one isoform can be stimulated by gua-
nosine S'-triphosphate (GTP) (12, 13).
Numerous studies have demonstrated increased and de-
creased ornithine decarboxylase activities in benign co-
lonic adenomas (14-17) and in colon carcinomas (17-
23). Ornithine decarboxylase levels have been shown to
differ as much as 2—100 fold between different
laboratories (24—26). Studies published until now have
not systematically investigated the range of normal
levels of ornithine decarboxylase in subjects without or-
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ganic intestinal diseases. Without these data, however,
the interpretation of ornithine decarboxylase assays in
pathological colonic mucosa remains unclear and its use
to detect possible malignant transformation must be
questionable.
In order to determine a reference range of ornithine de-
carboxylase activity in different parts of the colon we
examined ornithine decarboxylase levels in normally ap-
pearing colonic mucosa in male and female subjects of
different ages.
Materials and Methods
Patients
Twenty patients (11 women, 9 men) aged 17—78 (mean 47.7) years
were included in the study. All patients had unclear abdominal
symptoms and underwent total colonoscopy. Organic intestinal dis-
eases were excluded. There was also no evidence for systemic dis-
eases such as carcinomas, diabetes, infections, hepatic or renal in-
sufficiency. Blood tests as haemoglobin, erythrocyte sedimentation
rate and leukocyte count were normal and there was no history of
prior colonic disease. Informed consent was obtained from all sub-
jects according to the Helsinki Declaration.
Biopsy procedures
The colonic cleansing was performed with senna and Golytely la-
vage as previously described by Ziegenhagen et al. (27). Biopsies
were taken from the caecum, ascending, transverse, descending,
sigmoid and rectum by a biopsy forceps (Olympus FB-24Q). Tis-
sue biopsies were placed immediately in liquid nitrogen for ornith-
ine decarboxylase analyses and in formaldehyde for microscopical
examination. These biopsies for ornithine decarboxylase analyses
were subsequently stored at -80 °C until the assay was done dur-
ing the next three weeks.
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The biopsies were considered to be "normal" when either the en-
doscopist found normally appearing mucosa and the pathologist
did not find any pathological alterations.
Assays
Homogenization and the assay for omithine decarboxylase were
done as a slight modification of the method of Haarsfad et al. (28).
The specimens were weighed and homogenized by an ice-cooled
Dounce glass/glass homogenizer 1 g/20 ml in homogenizing buffer
consisting of 50 mmol/1 Tris buffer (pH 7.5), 0.2 mmol/1 pyridoxal-
5-phosphate, 0.5 mmol/1 ethylenediaminetetraacetate (EDTA),
2 mmol/1 dithiothreitol, 0.2 mmol/1 freshly added phenylmethylsul-
phonyl fluoride. The homogenates were centrifuged at 46320g
(Heraeus Biofuge 28 RS) for 30 min at 4 °C. The supernatant was
immediately mixed with an equal volume of storage buffer (glyc-
erol, volume fraction 0.84, 1 mmol/1 EDTA, 0.4 mmol/1 pyridoxal-
5-phosphate and stored at -20 °C for subsequent analyzes. This
cytosol-glycerol fraction was assayed for ornithine decarboxylase
activity (protein content 1 g/1).
In 5 specimens an aliquot of the homogenate was also centrifuged
for 1 hour at 100 000 g in the ultracentrifuge (Beckman Optima L)
and the supernatant was mixed with storage buffer (1 + 1).
Also in 5 specimens an aliquot of the 46 320 g supernatant was
dialyzed overnight at 4 °C against 100 volumes of homogeniza-
tion buffer.
Ornithine decarboxylase activity was measured by the release of
14CO2 from £>L-[l-14C]ornithine as previously described by Rus-
sell & Snyder (1) and modified by Haarstad et al. (28) and L ser
et al. (29). All measurements were done twice in a tight fitting
rubber capped silic nized test tube, fitted with a syringe.
The standard assay mixture contained in a.total reaction volume of
200 μΐ: 30 μΐ cytosol-glycerol fraction (containing 28-32 μg pro-
tein), 18.5 KBq (0.5 μΟί) £>!-[!-13C]ornithine hydrochloride
(2094.2 GBq/mol = 56.6 mCi/mmol) Amersham-Buchler, Braun-
schweig, Germany, Lot-No: 69) and final concentrations of 46
mmol/1 Tris pH 7.5, 0.538 mmol/1 EDTA, 1.85 mmol/1 dithiothrei-
tol and 0.215 mmol/1 pyridoxal-5-phosphate. The released 14CO2
was trapped by a piece of Whatman filter paper (No. 1MM, 0.65
mm2) impregnated with 25 μΐ of the CO2 trapping agent hyamine
hydroxide (1 mol/1 in methanol) (Sigma Inc., Munich). After an
incubation time of 60 min at 37 °C in a shaking bath the reaction
was stopped by injection of 200 μΐ 6 mol/1 perchloric acid through
the rubber stopper. The incubation was continued routinely for an-
other 30 min at 37 °C to ensure complete absorption of 14CO2. In
22 cases the incubation was continued for 60 min. The radioactivity
on the filter papers was counted with a -counter Wallac 1410
(Pharmacia). To avoid chemiluminescence, the papers were
counted 24 hours later standing at room temperature in the dark in
10 ml Quickszint 1 (Zinsser Analytic, Frankfurt, Germany). Blanks
containing assay buffer alone or with bovine serum albumin in the
same concentration as the protein content in the cytosol-glycerol
mixture were included.
To be sure that the supernatants are free of mitochondrial ornithine-
2-oxo-acid aminotransferase2) which can also release CO2 from
omithine via the glutamate-2-oxo-glutarate pathway the activity of
the first 51 enzyme assays were performed also in the presence of
final concentrations of 10 μιηοΐ/ΐ aminooxyacetate which inhibits
the aminotransferase activity without affecting the measurement of
ornithine decarboxylase (30). Omithine decarboxylase activity was
also measured in final concentrations of 56 μηιοΙ/1 α-difluorometh-
ylornithine (Merrell Dow Pharma, R sselsheim, Germany), an
irreversible inhibitor of ornithine decarboxylase (120 biopsies)
(31). Furthermore, the ornithine decarboxylase activity was assayed
in the presence of GTP in final concentrations of 70 μπιοΐ/ΐ (114
biopsies). This is a sensitive method to detect a qualitatively dif-
ferent ornithine decarboxylase isoform (12, 13, 32). One unit of
ornithine decarboxylase activity is defined as the amount releasing
1 nmol of CO2 from L-ornithine per hour at 37 °C. Specific activity
is expressed as nmol C02 per hour per mg protein, measured in
the cytosol-glycerol fractions. Protein analyses were performed in
duplicate as described by Bradford (33) using bovine serum albu-
min as a standard.
Results
We examined 120 regional colonic mucosal biopsies, all
obtained at standard conditions, for determination of or-
nithine decarboxylase activity. The enzyme analyses
were performed within three weeks. During this time
there was no loss of enzyme activity. The ornithine de-
carboxylase activity in the cytosol-glycerol mixtures re-
mained stable. Some of the extracts (n = 29) we have
tested several months later still showed the same re-
sults (tab. 1).
Enzyme determination (2 replicates) of the same cyto-
sol-glycerol fractions was done with an intra-assay
coefficient of 5.0% in all 120 biopsies, respectively.
Different procedures of the supernatant as ultracentrif-
ugation and dialysis did not alter the results. The
differences of the ornithine decarboxylase activity of
the 46320g supernatant and the 100 000 g supernatant
were 4.0%. The ornithine decarboxylase activity of the
non-dialyzed and the dialyzed cytosol supernatant also
showed no significant differences (2.5%). Due to the
lacking effects of ultracentrifugation and dialysis we
limited this procedures to the first five specimens. The
addition of bovine serum albumin to our assay blank
in the same concentration as the protein content in
the cytosol-glycerol mixture (about 30 μg protein)
showed the same result as compared with the assay
buffer alone (mean 49 counts/min without bovine se-
rum albumin, 52 counts/min with bovine serum albu-
min, 5 cytosol-glycerol-fractions tested).
The addition of aminooxyacetate to the first 51 assays
of specimens from all six segments from proximal to
distal colon showed no difference to those assays with-
out aminooxyacetate (-3.5% to -f 2.5%). Thus, our cy-
tosol-glycerol fractions were free from the non-specific
Tab. 1 Effect of storage (-20 °C) of cytosol-glycerol mixture
from different biopsies on ornithine decarboxylase activity shown
in 9 representative experiments
Ornithine decarboxylase activity
Sigma
Caecum
Rectum
Transverse
Ascending
Rectum
Rectum
Rectum
Rectum
fresh
(1 day)
0.67
0.29
0.29
0.51
0.24
0.32
0.58
0.61
0.28
2 weeks
0.66
0.28
0.53
0.30
0.61
0.57
months
0.27 (3 months)
0.26 (6 months)
0.51 (2 months)
0.25 (1 month)
0.29 (12 months)
Ornithine decarboxylase values are given as 14CO2 liberated in
nmol/h · mg protein
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ornithine decarboxylase independent formation of 14CO2
from £>L-[l-I4C]ornithine by the mitochondrial aniino-
transferase.
An incubation time longer than 30 min after acidifying
the incubation mixture did not influence the results (10
cytosol-glycerol fractions tested).
The mean ornithine decarboxylase levels of all our
subjects given as CO2 liberated ranged from 0.26
± 0.08 nmol/h · mg protein to 0.44 ±0.16 nmol/h ·
mg protein and showed a slight increase according to
the localization from proximal to distal colon with a
considerable variation within each regional group.
As also shown in table 2 there were no differences
between sex and age.
Ornithine decarboxylase in normal mucosa was not
stimulated by GTP. The ornithine decarboxylase activity
of the specimens with GTP was on an average 1.01 fold
ofthat without GTP (range from 0.97 to 1.06), measured
in 114 biopsies. α-Difluoromethylornithine reduced the
ornithine decarboxylase activity in all 120 biopsies by
an average of 97.1% (96.5%-97.5%).
Discussion
We described a level of ornithine decarboxylase activity
for normal human subjects whose age overlap with the
risk for colorectal cancer. The determination of ornithine
decarboxylase activity might be important for the detec-
tion of malignant and premalignant diseases of the co-
lon. There are a lot of methodical discrepancies de-
scribed in different papers (1, 25, 26, 28, 29). Different
methods and procedures can significantly influence the
results. As we could show in our standardized assay,
ornithine decarboxylase activity can be measured with
reasonable precision and reproducibility.
The addition of glycerol, pyridoxal-5-phosphate and
EDTA to the cytosolic supernatant has a protective ef-
fect on the storage of the extract if frozen for months at
—20 °C (28, 29). As we could show in some of our
experiments, it is not necessary to perform an ultracen-
trifugation of the homogenate. On the other hand the
centrifugation procedure described by Garewal et al.
(34): 5 min at 10 000 g, does not seem sufficient to elim-
inate all mitochondria. Therefore, mitochondrial ornith-
ine decarboxylase activity and especially mitochondrial
aminotransferase activity can influence the results. Due
to our measurements in presence and absence of amino-
oxyacetate, an inhibitor of mitochondrial aminotransfer-
ase, we could show that our procedure is sufficient and
that our results reflect the activity of the cytosolic active
ornithine decarboxylase only.
Dialysis of the homogenate was suggested for the elimi-
nation of endogenous ornithine, or the small protein
antizyme (35) which possibly could dilute the radioac-
tive assay or inhibit the reaction. As we could show,
there was no difference between the dialyzed and the
non-dialyzed extracts. Thus, these products are neglig-
ible and do not play an important role in the ornithine
decarboxylase assay.
The addition of bovine serum albumin to our assay in
the same concentration as the protein content in the cy-
tosol-glycerol mixture showed the same result as com-
pared with the assay buffer alone. The protein concen-
tration of about 30 μg in our standardized enzyme assay
has been high enough for reproducible results. This is
also different to the ornithine decarboxylase assay used
by Garewal et al. (34).
An α-difluoromethylornithine corrected control of the
ornithine decarboxylase assay is often recommended.
The addition of α-difluoromethylornithine as a "back-
ground" sample may be acceptable in the ornithine
decarboxylase assay of normally appearing mucosa.
But using an ornithine decarboxylase assay with ex-
tracts from cancer mucosa which is often less inhibited
Tab. 2 Specific ornithine decarboxylase activity from proximal to distal normal colonic mucosa in
20 subjects and differentiated by sex and age
Omithine decarboxylase activity
Caecum
All
(n = 20)
Men
(n = 9)
Women
(n= 11)
<50 years
(n = 10)
>50 years
(n = 10)
0.26
0.23
0.28
0.25
0.26
±0.08
±0.08
±0.08
±0.07
±0.10
Ascending
0.27
0.28
0.26
0.24
0.30
±0.11
±0.11
±0.11
±0.12
±0.08
Transverse
0.31
0.35
0.27
0.26
0.38
±0.14
±0.14
±0.14
±0.12
±0.15
Descending
0.35
0.40
0.30
0.29
0.42
±0.18
±0.21
±0.16
±0.15
±0.21
Sigmoid
0.40
0.47
0.33
0.36
0.44
±0.20
±0.19
±0.20
±0.23
±0.17
Rectum
0.44 ±0.1 6
0.48 ±0.1 5
0.41 ± 0.17
0.42 ±0.1 5
0.46 ±0.1 8
Mean values of ornithine decarboxylase ± standard deviation are given as 14CO2 liberated in nmol/h · mg protein
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by α-difluoromethylornithine ((13), and our unpub-
lished data), an α-difluoromethylornithine corrected
control would give an uncorrect "background" reading.
The α-difluoromethylornithine inhibition of 97.1% is
also an indicator for the homogenicity of the ornithine
decarboxylase measured in normal mucosa. The re-
maining activity is the result of unspecific decarboxyl-
ases. The lower α-difluoromethylornithine inhibition
rate which was found in some carcinoma tissues (15)
was not detectable in our specimens of normal mu-
cosa.
Until now little is known about the intra- and inter-indi-
vidual variability of ornithine decarboxylase in normal
subjects. Our study shows a slight increase of ornithine
decarboxylase levels from the caecum towards the rec-
tum. This effect was detectable in 17 of our 20 patients,
two showed no increase and one a slight decrease. The
reason for this increase remains unclear, an elevated cell
turnover in the distal parts of the colon might play a
role. No difference according to age and sex could be
found. In contrast to our findings the results of Hixson
et al. (23, 36) showed no variation in the ornithine de-
carboxylase activity with bowel location. He measured
the ornithine decarboxylase activity in apparently unaf-
fected colorectal mucosa but with known neoplastic
lesions. The interpretation as "normal" colonic mucosa
must therefore be questionable.
The presence of a GTP activatable ornithine decarboxyl-
ase which is described in carcinoma tissue (12, 13, 32)
could not be found in normal colonic mucosa.
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